Home688266 • SHA
add
Suzhou Zelgen Biopharmaceuticals Co Ltd
Previous close
¥107.32
Day range
¥107.89 - ¥113.62
Year range
¥58.00 - ¥134.17
Market cap
28.31B CNY
Avg Volume
3.31M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 217.79M | 51.85% |
Operating expense | 208.28M | 18.06% |
Net income | -20.61M | 34.29% |
Net profit margin | -9.46 | 56.74% |
Earnings per share | — | — |
EBITDA | 5.70M | 118.01% |
Effective tax rate | 4.20% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.09B | -5.32% |
Total assets | 3.01B | 1.56% |
Total liabilities | 1.86B | 12.02% |
Total equity | 1.15B | — |
Shares outstanding | 264.71M | — |
Price to book | 24.73 | — |
Return on assets | -0.42% | — |
Return on capital | -0.55% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -20.61M | 34.29% |
Cash from operations | 286.35K | 100.62% |
Cash from investing | -4.21M | 84.48% |
Cash from financing | -26.60M | 78.29% |
Net change in cash | -30.60M | 84.40% |
Free cash flow | -94.18M | -230.43% |
About
Founded
Mar 18, 2009
Website
Employees
910
